Phibro Animal Health Files 8-K on Financial Results & Exhibits

TL;DR

**PAHC filed an 8-K for financial results, watch for the numbers.**

AI Summary

Phibro Animal Health Corporation filed an 8-K on February 7, 2024, to report on its "Results of Operations and Financial Condition" and "Financial Statements and Exhibits." This filing indicates that the company is providing an update on its financial performance, which is crucial for investors to understand the company's current health and future prospects. While specific numbers aren't detailed in this particular filing, the event itself signals an upcoming or concurrent release of financial data, which could impact the stock price (PAHC) depending on whether the results beat or miss expectations.

Why It Matters

This filing signals that Phibro Animal Health is providing an update on its financial performance, which is critical for investors to assess the company's health and make informed decisions about their investment in PAHC.

Risk Assessment

Risk Level: medium — The risk level is medium because while the filing itself is routine, the actual financial results it references could contain positive or negative surprises impacting the stock.

Analyst Insight

A smart investor would look for the actual financial statements and results that this 8-K references to understand the company's performance and potential impact on PAHC stock.

Key Players & Entities

• Phibro Animal Health Corporation (company) — the registrant filing the 8-K
• February 7, 2024 (date) — date of the earliest event reported and filing date
• NASDAQ Stock Market (company) — exchange where PAHC Class A Common Stock is registered
• PAHC (company) — trading symbol for Phibro Animal Health Corporation

FAQ

Key Financial Figures

• $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share PAHC NASDAQ Sto

Filing Documents

• pahc-20240207x8k.htm (8-K) — 31KB
• pahc-20240207xex99d1.htm (EX-99.1) — 780KB
• pahc-20240207xex99d1001.jpg (GRAPHIC) — 9KB
• 0001558370-24-000864.txt ( ) — 974KB
• pahc-20240207.xsd (EX-101.SCH) — 3KB
• pahc-20240207_lab.xml (EX-101.LAB) — 16KB
• pahc-20240207_pre.xml (EX-101.PRE) — 10KB
• pahc-20240207x8k_htm.xml (XML) — 5KB

02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On February 7, 2024, Phibro Animal Health Corporation issued a press release announcing its operating results for the fiscal quarter ended December 31, 2023 and updated financial guidance for the fiscal year ending June 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in this report, including the exhibit attached hereto, is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of, or otherwise regarded as filed under, the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01 FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated February 7, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. PHIBRO ANIMAL HEALTH CORPORATION Registrant Date: February 7, 2024 By: /s/ Judith Weinstein Name: Judith Weinstein Title: Senior Vice President, General Counsel and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR